Bio Protocol vs SUPRA — how do they compare? Bio Protocol trades at Rp513.28 (market cap Rp1,15T, Rp256,3M 24h volume), while SUPRA trades at Rp3.74 (market cap Rp121,98M, Rp4,1M 24h volume). The key difference: Bio Protocol is far larger — about 9427.8× SUPRA's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 32,5B / 100B SUPRA (33%) for SUPRA. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and SUPRA for 15 Days on average.
| BIO | SUPRA | |
|---|---|---|
Market Cap | Rp1,15T | Rp121,98M |
Volume (24h) | Rp256,3M | Rp4,1M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 32,5B / 100B SUPRA (33%) |
Typical Hold Time | 16 Days | 15 Days |
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Supra is the first blockchain built for Automatic DeFi (AutoFi), an automated financial system. As a Layer-1 solution, it supports high-speed smart contracts with integrated data and AI oracles, automation, and cross-chain messaging. This allows for innovative AutoFi features that generate revenue and redistribute it to applications and node operators, reducing reliance on block rewards over time. The Supra stack also provides AI agents with the tools needed to create and execute effective AutoFi strategies for users in a fully on-chain, secure, and autonomous manner.
Read more on SUPRA →